Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with small cell lung cancer (SCLC) or a type of cancer called a neuroendocrine tumor, confirmed through laboratory testing of tissue samples.
- People whose treating doctor considers them a suitable candidate for treatment with a medicine called tarlatamab.
- People who are over 18 years of age.
- People who have signed a written consent form agreeing to participate, including a privacy-related agreement, in line with the requirements of the institution running the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who do not meet all of the inclusion criteria listed above.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Number of blood samples collected to better characterize tarlatamab in real-world setting
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.